1
|
Scharner S, Stengel A. Animal Models for Anorexia Nervosa-A Systematic Review. Front Hum Neurosci 2021; 14:596381. [PMID: 33551774 PMCID: PMC7854692 DOI: 10.3389/fnhum.2020.596381] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Accepted: 12/16/2020] [Indexed: 12/16/2022] Open
Abstract
Anorexia nervosa is an eating disorder characterized by intense fear of gaining weight and a distorted body image which usually leads to low caloric intake and hyperactivity. The underlying mechanism and pathogenesis of anorexia nervosa is still poorly understood. In order to learn more about the underlying pathophysiology of anorexia nervosa and to find further possible treatment options, several animal models mimicking anorexia nervosa have been developed. The aim of this review is to systematically search different databases and provide an overview of existing animal models and to discuss the current knowledge gained from animal models of anorexia nervosa. For the systematic data search, the Pubmed—Medline database, Embase database, and Web of Science database were searched. After removal of duplicates and the systematic process of selection, 108 original research papers were included in this systematic review. One hundred and six studies were performed with rodents and 2 on monkeys. Eighteen different animal models for anorexia nervosa were used in these studies. Parameters assessed in many studies were body weight, food intake, physical activity, cessation of the estrous cycle in female animals, behavioral changes, metabolic and hormonal alterations. The most commonly used animal model (75 of the studies) is the activity-based anorexia model in which typically young rodents are exposed to time-reduced access to food (a certain number of hours a day) with unrestricted access to a running wheel. Of the genetic animal models, one that is of particular interest is the anx/anx mice model. Animal models have so far contributed many findings to the understanding of mechanisms of hunger and satiety, physical activity and cognition in an underweight state and other mechanisms relevant for anorexia nervosa in humans.
Collapse
Affiliation(s)
- Sophie Scharner
- Department for Psychosomatic Medicine, Charité Center for Internal Medicine and Dermatology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Andreas Stengel
- Department for Psychosomatic Medicine, Charité Center for Internal Medicine and Dermatology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.,Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany
| |
Collapse
|
2
|
Effect of different levels of hydrolysable tannin intake on the reproductive hormones and serum biochemical indices in healthy female rats. Sci Rep 2020; 10:20600. [PMID: 33244120 PMCID: PMC7692459 DOI: 10.1038/s41598-020-77672-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Accepted: 11/17/2020] [Indexed: 01/30/2023] Open
Abstract
The present work aimed to find out the effect of different levels of hydrolysable tannin (HT) on serum hormonal profile, biochemical indices, lipid profile, apparent digestibility of nutrients and body weight gain in healthy female rats. Forty five adult healthy female rats of 8 weeks old were randomly divided into five equal groups. Different doses of HT 0, 0.5, 1, 1.5 and 2% were administered daily to each rats group on the body weight basis for 6 weeks. The results had shown the reduction trend (p < 0.05) in the blood glucose, serum cholesterol, low density lipoprotein, testosterone, prolactin, ghrelin, total oxidative stress and serum iron levels; while an improvement (p < 0.05) was seen in serum follicle stimulating hormone, progesterone, luteinizing hormone, high density lipoprotein, IgM and total antioxidant capacity. However, no effect (p > 0.05) was noticed in serum IgG, protein, estrogen and calcium levels. A significant reduction (p < 0.05) was seen in the apparent nutrient digestibility and body weight gain. The results had shown improvement in the feed conversion ratio (p < 0.05) but non-significant decrease (p > 0.05) in the feed intake. The findings showed that HT had healthy effects on the serum biochemical indices and reproductive hormonal profile but had a negative impact on the nutrient digestibility. Thus, the study concluded that HT could be used as an herbal medicine for the treatment of leading metabolic and infertility diseases like obesity and polycystic ovarian syndrome in females.
Collapse
|
3
|
Gilman TL, Owens WA, George CM, Metzel L, Vitela M, Ferreira L, Bowman MA, Gould GG, Toney GM, Daws LC. Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm. J Pharmacol Exp Ther 2019; 371:268-277. [PMID: 31481515 PMCID: PMC6795746 DOI: 10.1124/jpet.119.260794] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2019] [Accepted: 08/21/2019] [Indexed: 01/06/2023] Open
Abstract
Eating disorders such as anorexia typically emerge during adolescence, are characterized by engagement in compulsive and detrimental behaviors, and are often comorbid with neuropsychiatric disorders and drug abuse. No effective treatments exist. Moreover, anorexia lacks adolescent animal models, contributing to a poor understanding of underlying age-specific neurophysiological disruptions. To evaluate the contribution of dopaminergic signaling to the emergence of anorexia-related behaviors during the vulnerable adolescent period, we applied an established adult activity-based anorexia (ABA) paradigm (food restriction plus unlimited exercise access for 4 to 5 days) to adult and adolescent rats of both sexes. At the end of the paradigm, measures of plasma volume, blood hormone levels, dopamine transporter (DAT) expression and function, acute cocaine-induced locomotion, and brain water weight were taken. Adolescents were dramatically more affected by the ABA paradigm than adults in all measures. In vivo chronoamperometry and cocaine locomotor responses revealed sex-specific changes in adolescent DAT function after ABA that were independent of DAT expression differences. Hematocrit, insulin, ghrelin, and corticosterone levels did not resemble shifts typically observed in patients with anorexia, though decreases in leptin levels aligned with human reports. These findings are the first to suggest that food restriction in conjunction with excessive exercise sex-dependently and age-specifically modulate DAT functional plasticity during adolescence. The adolescent vulnerability to this relatively short manipulation, combined with blood measures, evidence need for an optimized age-appropriate ABA paradigm with greater face and predictive validity for the study of the pathophysiology and treatment of anorexia. SIGNIFICANCE STATEMENT: Adolescent rats exhibit a distinctive, sex-specific plasticity in dopamine transporter function and cocaine response after food restriction and exercise access; this plasticity is both absent in adults and not attributable to changes in dopamine transporter expression levels. These novel findings may help explain sex differences in vulnerability to eating disorders and drug abuse during adolescence.
Collapse
Affiliation(s)
- T Lee Gilman
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - W Anthony Owens
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Christina M George
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Lauren Metzel
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Melissa Vitela
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Livia Ferreira
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Melodi A Bowman
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Georgianna G Gould
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Glenn M Toney
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Lynette C Daws
- Department of Cellular and Integrative Physiology (T.L.G., W.A.O., C.M.G., L.M., M.V., L.F., M.A.B., G.G.G., G.M.T., L.C.D.), Addiction Research, Treatment & Training Center of Excellence (T.L.G., L.C.D.), Center for Biomedical Neuroscience (G.M.T., L.C.D.), and Department of Pharmacology (L.C.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas
| |
Collapse
|
4
|
C de Oliveira D, Santos EW, Nogueira-Pedro A, Xavier JG, Borelli P, Fock RA. Effects of short-term dietary restriction and glutamine supplementation in vitro on the modulation of inflammatory properties. Nutrition 2018; 48:96-104. [PMID: 29469028 DOI: 10.1016/j.nut.2017.11.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2017] [Revised: 10/21/2017] [Accepted: 11/04/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVE Dietary restriction (DR) is a nutritional intervention that exerts profound effects on biochemical and immunologic parameters, modulating some inflammatory properties. Glutamine (GLN) is a conditionally essential amino acid that can modulate inflammatory properties. However, there is a lack of data evaluating the effects of DR and GLN supplementation, especially in relation to inflammatory cytokine production and the expression of transcription factors such as nuclear factor (NF)-κB. METHODS We subjected 3-mo-old male Balb/c mice to DR by reducing their food intake by 30%. DR animals lost weight and showed reduced levels of serum triacylglycerols, glucose, cholesterol, and calcium as well as a reduction in bone density. Additionally, blood, peritoneal, and spleen cellularity were reduced, lowering the number of peritoneal F4/80- and CD86-positive cells and the total number of splenic CD4- and CD8-positive cells. RESULTS The production of interleukin (IL)-10 and the expression of NF-κB in splenic cells were not affected by DR or by GLN supplementation. However, peritoneal macrophages from DR animals showed reduced IL-12 and tumor necrosis factor-α production and increased IL-10 production with reduced phosphorylation of NF-κB expression. Additionally, GLN was able to modulate cytokine production by peritoneal cells from the control group, although no effects were observed in cells from the DR group. CONCLUSION DR induces biochemical and immunologic changes, in particular by reducing IL-12 and tumor necrosis factor-α production by macrophages and clearly upregulating IL-10 production, whereas GLN supplementation did not modify these parameters in cells from DR animals.
Collapse
Affiliation(s)
- Dalila C de Oliveira
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
| | - Ed Wilson Santos
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| | - Amanda Nogueira-Pedro
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| | - José Guilherme Xavier
- School of Veterinary Medicine, Institute of Health Science Paulista University, Sao Paulo, Brazil
| | - Primavera Borelli
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| | - Ricardo Ambrósio Fock
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
5
|
Böser P, Mordashova Y, Maasland M, Trommer I, Lorenz H, Hafner M, Seemann D, Mueller BK, Popp A. Quantification of Hepcidin-related Iron Accumulation in the Rat Liver. Toxicol Pathol 2016; 44:259-66. [PMID: 26839325 DOI: 10.1177/0192623315623866] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Hepcidin was originally detected as a liver peptide with antimicrobial activity and it functions as a central regulator in the systemic iron metabolism. Consequently suppression of hepcidin leads to iron accumulation in the liver. AbbVie developed a monoclonal antibody ([mAb]; repulsive guidance molecule [RGMa/c] mAb) that downregulates hepcidin expression by influencing the RGMc/bone morphogenetic protein (BMP)/neogenin receptor complex and causes iron deposition in the liver. In a dose range finding study with RGMa/c mAb, rats were treated with different dose levels for a total of 4 weekly doses. The results of this morphometric analysis in the liver showed that iron accumulation is not homogenous between liver lobes and the left lateral lobe was the most responsive lobe in the rat. Quantitative hepcidin messenger RNA analysis showed that the left lateral lobe was the most responsive lobe showing hepcidin downregulation with increasing antibody dose. In addition, the morphometric analysis had higher sensitivity than the chemical iron extraction and quantification using a colorimetric assay. In conclusion, the Prussian blue stain in combination with semi-quantitative and quantitative morphometric analysis is the most reliable method to demonstrate iron accumulation in the liver compared to direct measurement of iron in unfixed tissue using a colorimetric assay.
Collapse
Affiliation(s)
- Preethne Böser
- AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany Institute for Medical Technology, Heidelberg University and University of Applied Sciences Mannheim, Ludwigshafen, Germany
| | | | - Mark Maasland
- Fraunhofer Institute for Industrial Mathematics ITWM, Kaiserslautern, Ludwigshafen, Germany
| | | | - Helga Lorenz
- AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
| | - Mathias Hafner
- Institute for Medical Technology, Heidelberg University and University of Applied Sciences Mannheim, Ludwigshafen, Germany
| | | | | | - Andreas Popp
- AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
| |
Collapse
|
6
|
Senuma M, Mori C, Ogawa T, Kuwagata M. Prenatal sodium arsenite affects early development of serotonergic neurons in the fetal rat brain. Int J Dev Neurosci 2014; 38:204-12. [PMID: 25291237 DOI: 10.1016/j.ijdevneu.2014.09.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2014] [Revised: 09/26/2014] [Accepted: 09/26/2014] [Indexed: 10/24/2022] Open
Abstract
Prenatal arsenite exposure has been associated with developmental disorders in children, including reduced IQ and language abnormalities. Animal experiments have also shown that exposure to arsenite during development induced developmental neurotoxicity after birth. However, the evidence is not enough, and the mechanism is poorly understood, especially on the exposure during early brain development. This study assessed effects of sodium (meta) arsenite shortly after exposure on early developing fetal rat brains. Pregnant rats were administered 50 mg/L arsenite in their drinking water or 20 mg/kg arsenite orally using a gastric tube, on gestational days (GD) 9-15. Fetal brains were examined on GD16. Pregnant rats administered 20 mg/kg arsenite showed reductions in maternal body weight gain and food consumption during treatment, but not with 50 mg/L arsenite. Arsenite did not affect fetal development, as determined by body weight, mortality and brain size. Arsenite also did not induce excessive cell death or affect neural cell division in any region of the fetal neuroepithelium. Thyrosine hydroxylase immunohistochemistry revealed no difference in the distribution of catecholaminergic neurons between fetuses of arsenite treated and control rats. However, reductions in the number of serotonin positive cells in the fetal median and dorsal raphe nuclei were observed following maternal treatment with 20mg/kg arsenite. Image analysis showed that the serotonin positive areas decreased in all fetal mid- and hind-brain areas without altering distribution patterns. Maternal stress induced by arsenite toxicity did not alter fetal development. These results suggest that arsenite-induced neurodevelopmental toxicity involves defects in the early development of the serotonin nervous system.
Collapse
Affiliation(s)
- Mika Senuma
- Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-8523, Japan.
| | - Chisato Mori
- Department of Bioenvironmental Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City 260-8670, Japan.
| | - Tetsuo Ogawa
- Department of Biology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
| | - Makiko Kuwagata
- Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-8523, Japan.
| |
Collapse
|